Wathsala Manindrani: Managing Severe Hypertriglyceridemia in Resource-Limited Settings
Wathsala Manindrani, Transfusion Medicine Senior Registrar at National Cancer Institute, Sri Lanka, shared a post on LinkedIn:
“Managing severe hypertriglyceridaemia can be challenging, specially in resource-limited settings.
Recently, we managed a patient with familial hypertriglyceridaemia requiring urgent lipid reduction.
An automated Therapeutic Plasma Exchange (TPE) was initially attempted.
However, due to the extremely high triglyceride levels, the procedure could not be continued as the machine generated persistent alarms related to the lipemic plasma.
In Sri Lanka, Lipoprotein Apheresis (LA) using lipoadsorption columns is not currently available.
Therefore, our team proceeded with a manual plasma exchange, which allowed us to successfully remove the lipemic plasma and continue the therapeutic intervention.
This case highlights how clinical adaptability and teamwork are essential in transfusion medicine, particularly in settings where advanced apheresis technologies are limited.
Even with resource constraints, effective patient care can be achieved through thoughtful modification of available techniques.”
Stay updated with Hemostasis Today.
-
Jun 23, 2026, 23:05Rounak Dubey: ISBT Academy Session on Agentic AI
-
Jun 23, 2026, 22:59Mohammed Maher Babiker: Don’t Let EDTA Fool You – When ‘Low Platelets’ aren’t Really Low
-
Jun 23, 2026, 22:49Giovanni Merlino: Why Does Stress Hyperglycemia Worsen Stroke Outcomes?
-
Jun 23, 2026, 22:41Tareq Abadl: Coombs Test – The Key to Detecting Immune-Mediated Hemolysis
-
Jun 23, 2026, 22:32How WFH Impacted the Bleeding Disorders Community in 2025
-
Jun 23, 2026, 22:03Erin VanDyke: A Journey Through VTE Leadership and Healthcare Transformation
-
Jun 23, 2026, 20:30Aladdin Mohammad: Baseline IgG as a Key Predictor of Hypogammaglobulinaemia in AAV
-
Jun 23, 2026, 19:20Simos Kokkovos: 1st Ever Mobile Stroke Unit in Greece is on its way to Metropolitan Hospital
-
Jun 23, 2026, 18:27Advancing Gene Therapy Research for Glanzmann Thrombasthenia – Glanzmann’s Research Foundation